Xiidra, in a 5% solution formulation, is indicated for signs and symptoms of dry eye disease in adults, and is the only prescription eye drop approved for this use. The US Food and Drug ...

For the temporary relief of dry eye symptoms, discomfort due to minor eye irritations, or due to wind or sun exposure. As a protectant and lubricant to prevent further irritation or to relieve ...

For the temporary relief of dry eye symptoms, discomfort due to minor eye irritations, or due to wind or sun exposure. As a protectant and lubricant to prevent further irritation or to relieve ...

Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.

The "Dry Eye Disease - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.An in-depth report providing extensive information on the current therapeutic landscape for ...

Prospects for Aldeyra's dry eye disease candidate reproxalap were hit last month after the drug failed to hit its primary objective in a phase 3 trial, but the company isn't giving up and has new ...

According to a comprehensive report from The Insight Partners, "Dry Eye Products Market Size and Forecast 2023 - 2031, Global ...

The mucus comes from the conjunctiva which is the transparent tissue covering the whites of the eye and internal surface of ...

Aldeyra Therapeutics surges 15% to $4.10, following an upgrade from Oppenheimer citing the company's development plan for resubmitting a New Drug Application [NDA] for its dry eye disease ...

While dry eye doesn't have a cure, there are several relief options that can help alleviate symptoms, including prescription medications. Many factors can contribute to dry eye symptoms ...